The relationship between preeclampsia, pregnancy-induced hypertension and maternal risk of breast cancer: A meta-analysis

Acta Oncologica

Volumn 52, Issue 8, 2013, Pages 1643-1648

  Kim, Jung Sun ^a   Kang, Eun Joo ^a   Woo, Ok Hee ^a   Park, Kyong Hwa ^a   Woo, Sang Uk ^a   Yang, Dae Sik ^a   Kim, Ae Ree ^a   Lee, Jae Bok ^a   Kim, Yeul Hong ^a   Kim, Jun Suk ^a   Seo, Jae Hong ^a  

^a Korea University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BREAST CANCER; CANCER REGISTRY; CANCER RISK; CASE CONTROL STUDY; COHORT ANALYSIS; DATA BASE; DISEASE ASSOCIATION; HUMAN; MATERNAL HYPERTENSION; META ANALYSIS; PREECLAMPSIA; PRIORITY JOURNAL; PUBLISHING; SYSTEMATIC REVIEW; FEMALE; NORWAY;

BREAST NEOPLASMS; FEMALE; HUMANS; HYPERTENSION, PREGNANCY-INDUCED; PRE-ECLAMPSIA; PREGNANCY; PROGNOSIS; RISK FACTORS;

EID: 84885443022     PISSN: 0284186X     EISSN: 1651226X     Source Type: Journal    
DOI: 10.3109/0284186X.2012.750033     Document Type: Article

References (40)

1. Nechuta S, Paneth N, Velie EM. Pregnancy characteristics and maternal breast cancer risk: A review of the epidemio-logic literature. Cancer Causes Control 2010; 21: 967-89.
2. Russo J, Russo IH. Toward a physiological approach to breast cancer prevention. Cancer Epidemiol Biomarkers Prev 1994; 3: 353-64.
3. Schedin P. Pregnancy-associated breast cancer and metastasis. Nat Rev Cancer 2006; 6: 281-91.
4. Salamalekis E, Bakas P, Vitoratos N, Eleptheriadis M, Creatsas G. Androgen levels in the third trimester of pregnancy in patients with preeclampsia. Eur J Obstet Gynecol Reprod Biol 2006; 126: 16-9.
5. Acromite MT, Mantzoros CS, Leach RE, Hurwitz J, Dorey LG. Androgens in preeclampsia. Am J Obstet Gynecol 1999; 180: 60-3.
6. Innes KE, Byers TE. Preeclampsia and breast cancer risk. Epidemiology 1999; 10: 722-32.
7. Rosing U, Carlstrom K. Serum levels of unconjugated and total oestrogens and dehydroepiandrosterone, progesterone and urinary oestriol excretion in pre-eclampsia. Gynecol Obstet Invest 1984; 18: 199-205.
8. Isouard G. Measurement of serum levels of oestriol and human placental lactogen in the management of pre-eclamptic pregnancies. Med J Aust 1979; 2: 401-4.
9. Klopper A, Jandial V, Wilson G. Plasma steroid assay in the assessment of foetoplacental function. J Steroid Biochem 1975; 6: 651-6.
10. Stamilio DM, Sehdev HM, Morgan MA, Propert K, Macones GA. Can antenatal clinical and biochemical markers predict the development of severe preeclampsia? Am J Obstet Gynecol 2000; 182: 589-94.
11. Warren WB, Gurewitsch ED, Goland RS. Corticotropin-releasing hormone and pituitary-adrenal hormones in pregnancies complicated by chronic hypertension. Am J Obstet Gynecol 1995; 172: 661-6.
12. Masse J, Forest JC, Moutquin JM, Marcoux S, Brideau NA, Belanger M. A prospective study of several potential biologic markers for early prediction of the development of preec-lampsia. Am J Obstet Gynecol 1993; 169: 501-8.
13. Ranta T, Stenman UH, Unnerus HA, Rossi J, Seppala M. Maternal plasma prolactin levels in preeclampsia. Obstet Gynecol 1980; 55: 428-30.
14. Ekbom A, Trichopoulos D, Adami HO, Hsieh CC, Lan SJ. Evidence of prenatal infl uences on breast cancer risk. Lancet 1992; 340: 1015-8.
15. Le Marchand L, Kolonel LN, Myers BC, Mi MP. Birth characteristics of premenopausal women with breast cancer. Br J Cancer 1988; 57: 437-9.
16. Polednak AP, Janerich DT. Characteristics of first pregnancy in relation to early breast cancer. A case-control study. J Reprod Med 1983; 28: 314-8.
17. Terry MB, Perrin M, Salafia CM, Zhang FF, Neugut AI, Teitelbaum SL, et al. Preeclampsia, pregnancy-related hypertension, and breast cancer risk. Am J Epidemiol 2007; 165: 1007-14.
18. Innes KE, Byers TE. First pregnancy characteristics and subsequent breast cancer risk among young women. Int J Cancer 2004; 112: 306-11.
19. Richardson BE, Peck JD, Wormuth JK. Mean arterial pressure, pregnancy-induced hypertension, and preeclampsia: Evaluation as independent risk factors and as surrogates for high maternal serum alpha-fetoprotein in estimating breast cancer risk. Cancer Epidemiol Biomarkers Prev 2000; 9: 1349-55.
20. Troisi R, Weiss HA, Hoover RN, Potischman N, Swanson CA, Brogan DR, et al. Pregnancy characteristics and maternal risk of breast cancer. Epidemiology 1998; 9: 641-7.
21. Troisi R, Innes KE, Roberts JM, Hoover RN. Preeclampsia and maternal breast cancer risk by offspring gender: Do elevated androgen concentrations play a role? Br J Cancer 2007; 97: 688-90.
22. Calderon-Margalit R, Friedlander Y, Yanetz R, Deutsch L, Perrin MC, Kleinhaus K, et al. Preeclampsia and subsequent risk of cancer: Update from the Jerusalem Perinatal Study. Am J Obstet Gynecol 2009; 200: 63e1-5.
23. Ekbom A, Hsieh CC, Lipworth L, Adami HQ, Trichopoulos D. Intrauterine environment and breast cancer risk in women: A population-based study. J Natl Cancer Inst 1997; 89: 71-6.
24. Paltiel O, Friedlander Y, Tiram E, Barchana M, Xue X, Harlap S. Cancer after pre-eclampsia: Follow up of the Jerusalem perinatal study cohort. Br Med J 2004; 328: 919.
25. Vatten LJ, Forman MR, Nilsen TI, Barrett JC, Romundstad PR. The negative association between pre-eclampsia and breast cancer risk may depend on the offspring's gender. Br J Cancer 2007; 96: 1436-8.
26. Vatten LJ, Romundstad PR, Trichopoulos D, Skjaerven R. Pre-eclampsia in pregnancy and subsequent risk for breast cancer. Br J Cancer 2002; 87: 971-3.
27. Powe CE, Levine RJ, Karumanchi SA. Preeclampsia, a disease of the maternal endothelium: The role of antiangiogenic factors and implications for later cardiovascular disease. Circulation 2011; 123: 2856-69.
28. Cohn BA, Cirillo PM, Christianson RE, van den Berg BJ, Siiteri PK. Placental characteristics and reduced risk of maternal breast cancer. J Natl Cancer Inst 2001; 93: 1133-40.
29. Talamini R, Franceschi S, Favero A, Negri E, Parazzini F, La Vecchia C. Selected medical conditions and risk of breast cancer. Br J Cancer 1997; 75: 1699-703.
30. Thompson WD, Jacobson HI, Negrini B, Janerich DT. Hypertension, pregnancy, and risk of breast cancer. J Natl Cancer Inst 1989; 81: 1571-4.
31. Bachmann J, Feldmer M, Ganten U, Stock G, Ganten D. Sexual dimorphism of blood pressure: Possible role of the renin-angiotensin system. J Steroid Biochem Mol Biol 1991; 40: 511-5.
32. Gant NF, Hutchinson HT, Siiteri PK, MacDonald PC. Study of the metabolic clearance rate of dehydroisoandros-terone sulfate in pregnancy. Am J Obstet Gynecol 1971; 111: 555-63.
33. Hahnel ME, Martin JD, Michael CA, Hahnel R. Metabolism of androstenedione by placental microsomes in pregnancy hypertension. Clin Chim Acta 1989; 181: 103-8.
34. Troisi R, Potischman N, Roberts JM, Ness R, Crombleholme W, Lykins D, et al. Maternal serum oestrogen and androgen concentrations in preeclamptic and uncomplicated pregnancies. Int J Epidemiol 2003; 32: 455-60.
35. Hughes G, Bischof P, Wilson G, Smith R, Klopper A. Tests of fetal wellbeing in the third trimester of pregnancy. Br J Obstet Gynaecol 1980; 87: 650-6.
36. Waller DK, Lustig LS, Cunningham GC, Feuchtbaum LB, Hook EB. The association between maternal serum alpha-fetoprotein and preterm birth, small for gestational age infants, preeclampsia, and placental complications. Obstet Gynecol 1996; 88: 816-22.
37. Raty R, Koskinen P, Alanen A, Irjala K, Matinlauri I, Ekblad U. Prediction of pre-eclampsia with maternal mid-trimester total renin, inhibin A, AFP and free beta-hCG levels. Prenat Diagn 1999; 19: 122-7.
38. Kato S, Endoh H, Masuhiro Y, Kitamoto T, Uchiyama S, Sasaki H, et al. Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase. Science 1995; 270: 1491-4.
39. Mizejewski GJ, Vonnegut M, Jacobson HI. Estradiol-activated alpha-fetoprotein suppresses the uterotropic response to estrogens. Proc Natl Acad Sci U S A 1983; 80: 2733-7.
40. Atamer Y, Erden AC, Demir B, Kocyigit Y, Atamer A. The relationship between plasma levels of leptin and androgen in healthy and preeclamptic pregnant women. Acta Obstet Gynecol Scand 2004; 83: 425-30.